Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...
Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...
Cellular Origins announces the completion of a USD 40 million (EUR 34.3 million) over-subscribed Series A round. The Series A financing was led by Johnson & Johnson, through its corporate venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback